PL4129304T3 - Środek przeciwnowotworowy - Google Patents

Środek przeciwnowotworowy

Info

Publication number
PL4129304T3
PL4129304T3 PL21781882.2T PL21781882T PL4129304T3 PL 4129304 T3 PL4129304 T3 PL 4129304T3 PL 21781882 T PL21781882 T PL 21781882T PL 4129304 T3 PL4129304 T3 PL 4129304T3
Authority
PL
Poland
Prior art keywords
anticancer agent
anticancer
agent
Prior art date
Application number
PL21781882.2T
Other languages
English (en)
Inventor
Takeshi Matsumoto
Chihaya Kakinuma
Keiko Makita
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of PL4129304T3 publication Critical patent/PL4129304T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL21781882.2T 2020-04-03 2021-04-02 Środek przeciwnowotworowy PL4129304T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063004733P 2020-04-03 2020-04-03
JP2020086495 2020-05-18
PCT/JP2021/014285 WO2021201267A1 (ja) 2020-04-03 2021-04-02 抗腫瘍剤

Publications (1)

Publication Number Publication Date
PL4129304T3 true PL4129304T3 (pl) 2025-01-13

Family

ID=77929257

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21781882.2T PL4129304T3 (pl) 2020-04-03 2021-04-02 Środek przeciwnowotworowy

Country Status (15)

Country Link
EP (1) EP4129304B1 (pl)
JP (2) JP7733467B2 (pl)
CN (1) CN115551517A (pl)
AU (1) AU2021249949B2 (pl)
DK (1) DK4129304T3 (pl)
FI (1) FI4129304T3 (pl)
HR (1) HRP20241487T1 (pl)
HU (1) HUE069834T2 (pl)
LT (1) LT4129304T (pl)
PL (1) PL4129304T3 (pl)
PT (1) PT4129304T (pl)
RS (1) RS66088B1 (pl)
SI (1) SI4129304T1 (pl)
SM (1) SMT202400449T1 (pl)
WO (1) WO2021201267A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3138556B1 (en) 2014-04-30 2022-03-02 FUJIFILM Corporation Method for producing liposomes
WO2015166985A1 (ja) * 2014-04-30 2015-11-05 富士フイルム株式会社 リポソーム組成物及びその製造方法
EP3138558B1 (en) 2014-04-30 2023-06-07 FUJIFILM Corporation Liposome composition and production method therefor
DK3138555T3 (da) 2014-04-30 2020-12-14 Fujifilm Corp Liposomsammensætning og fremgangsmåde til fremstilling heraf
MA43184A (fr) 2015-11-02 2021-04-14 Fujifilm Corp Composition liposomale et son procédé de production
JP6602886B2 (ja) * 2015-11-02 2019-11-06 富士フイルム株式会社 ゲムシタビンリポソーム組成物を含む腫瘍治療剤およびキット
FI3811949T3 (fi) * 2018-06-20 2024-09-13 Fujifilm Corp Liposomikoostumukseen kapseloitua gemsitabiinia ja immuunitarkistuspistesalpaajaa käsittävä yhdistelmälääke

Also Published As

Publication number Publication date
CN115551517A (zh) 2022-12-30
EP4129304A1 (en) 2023-02-08
JP7733467B2 (ja) 2025-09-03
JP2024023887A (ja) 2024-02-21
AU2021249949A1 (en) 2022-10-27
SI4129304T1 (sl) 2025-03-31
LT4129304T (lt) 2024-11-11
EP4129304B1 (en) 2024-09-18
RS66088B1 (sr) 2024-11-29
EP4129304A4 (en) 2023-06-07
PT4129304T (pt) 2024-10-28
WO2021201267A1 (ja) 2021-10-07
JP2021181426A (ja) 2021-11-25
SMT202400449T1 (it) 2024-11-15
HUE069834T2 (hu) 2025-04-28
AU2021249949B2 (en) 2024-05-30
FI4129304T3 (fi) 2024-11-27
CA3173715A1 (en) 2021-10-07
HRP20241487T1 (hr) 2025-01-03
DK4129304T3 (da) 2024-12-09

Similar Documents

Publication Publication Date Title
EP3311841A4 (en) ANTI CANCER AGENTS
EP4107782A4 (en) MICROARRAYS
IL286651A (en) Anti-viral and anti-tumoral compounds
IL309099A (en) Anticancer compounds
EP3718545A4 (en) ANTI-TUMOR AGENT
EP3957265A4 (en) MICROSCOPE COVER
EP4063561C0 (en) REFINER SEGMENT
EP3849310A4 (en) COMBINATION CANCER THERAPIES
EP4198000C0 (de) Pt-xanthen-brom-komplex
EP4574809A4 (en) DESULFURRATION AGENT
EP3733206A4 (en) ANTI-CANCER AGENTS
EP4373344A4 (en) VULCANIZING AGENT
DE112021007890A5 (de) Kurzschließer
EP4288727C0 (de) Cryosauna
EP4130019A4 (en) Metal-carbohydrate complex
EP3880190A4 (en) ANTI-CANCER COMPOSITION
UA42999S (uk) Прохідницький комбайн
EP4455195A4 (en) COMPLEX
EP4288212A4 (en) HARDENING AGENT
TH2102004621S (th) หน้าตัด
TH2102004621A (th) หน้าตัด
EP4426152C0 (en) TOGETHER
TH2102003861S (th) หน้าตัด
TH2102003861A (th) หน้าตัด
TH2102003413A (th) หน้าตัด